This medication may be prescribed for other uses; ask your doctor or pharmacist for more information. NOTE: In view of the insufficient numbers of isolates of beta-lactamase—producing strains of Haemophilus influenzae and Moraxella catarrhalis that were obtained from clinical trials with cefuroxime axetil tablets for patients with acute bacterial maxillary sinusitis, it was not possible to adequately evaluate the effectiveness of cefuroxime axetil tablets for sinus infections known, suspected, or considered potentially to be caused by beta-lactamase—producing Haemophilus influenzae or Moraxella catarrhalis.
Cefuroxime may cause side effects. However, the incidence of gastrointestinal adverse events increased with the higher recommended doses. Table 2. Geriatric Use Of the total number of subjects who received cefuroxime axetil in 20 clinical studies of cefuroxime axetil, were 65 and over while were 75 and over.
If you need to switch from one cefuroxime product to another, your doctor may need to adjust your dose. Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus including beta-lactamase—producing strains or Streptococcus pyogenes.
Take the suspension with food; the tablet may be taken with or without food. Hypertoxin producing strains of C. Cefuroxime is in a class of medications called cephalosporin antibiotics.
Pediatric Use The safety and effectiveness of cefuroxime axetil have been established for pediatric patients aged 3 months to 12 years for acute bacterial maxillary sinusitis based upon its approval in adults. Before taking cefuroxime, tell your doctor and pharmacist if you are allergic to cefuroxime; other cephalosporin antibiotics such as cefaclorcefadroxil, cefazolin Ancef, Kefzolcefdinircefditoren Spectracefcefepime Maxipimecefixime,cefotaxime Claforancefotetan, cefoxitin Mefoxincefpodoximecefprozilceftaroline Teflaroceftazidime Fortaz, Tazicef, in Avycazceftibuten Cedaxceftriaxone Rocephinand cephalexin Keflex ; penicillin antibiotics; or any other medications.
There are no data from adequate and well-controlled trials to demonstrate the effectiveness of cefuroxime in the treatment of penicillin-resistant strains of Streptococcus pyogenes.